Search

Search Constraints

You searched for: Author/Creator Hisanaga, Yasuhiro

Search Results

2. Impact of COVID‐19 pandemic on surveillance of hepatocellular carcinoma: A study in patients with chronic hepatitis C after sustained virologic response. Issue 5 (3rd September 2020)

3. Impact of the branched‐chain amino acid to tyrosine ratio and branched‐chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis. Issue 9 (September 2015)

4. Oral supplementation with branched‐chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C‐related cirrhosis: A propensity score analysis. Issue 3 (29th April 2013)

5. Post‐treatment levels of α‐fetoprotein predict long‐term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C. Issue 10 (19th December 2016)

6. Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection. Issue 5 (17th April 2007)

7. Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection. Issue 7 (July 2015)

8. Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis. (12th February 2016)

9. Viral eradication reduces all‐cause mortality, including non–liver‐related disease, in patients with progressive hepatitis C virus‐related fibrosis. Issue 3 (March 2017)